As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's ...
The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...
Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...
Dividend payers are solid performers. One reason is that a company has to reach a point where it has some fairly dependable ...
Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback